Outcomes Following Non-Covalent BTK Inhibitor Treatment for CLL | Meghan C. Thompson, MD | ASH 2022 

Interview with Meghan C. Thompson, MD of Memorial Sloan Kettering Cancer Center at ASH 2022. Filmed December 11, 2022.
The HealthTree Foundation brings information from the experts to the patients! Learn more at healthtree.org/
Donate to the HealthTree Foundation or learn more about additional blood cancer support we offer here: give.healthtree.org/campaign/...
HealthTree Cure Hub helps you find your best treatment options and accelerate cure for blood cancers. Join today at www.healthtree.org/